A quantitative RT-PCR method to determine topoisomerase I mRNA levels in human tissue samples

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 7, 2005, Pages 707-714

  Durand Faucher, Karine ^a,b   Rabinovitch Chable, Hélène ^a   Dzugan, Hélène ^a   Charret, Stéphane ^a   Aubry, Karine ^a   Genet, Dominique ^a   Léobon, Sophie ^a   Tubiana Mathieu, Nicole ^a   Cook Moreau, Jeanne ^a   Rigaud, Michel ^a   Sturtz, Franck G ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF LIMOGES   (France)

Author keywords

Gene expression; mRNA quantification; RT PCR; Topoisomerase I

Indexed keywords

COMPLEMENTARY DNA; DNA TOPOISOMERASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PORPHOBILINOGEN DEAMINASE;

ACCURACY; ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER TISSUE; CELL TYPE; CLINICAL ARTICLE; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DILUTION; FEMALE; GENDER; GENE AMPLIFICATION; GENE EXPRESSION; HISTOPATHOLOGY; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; LARYNX CANCER; LYMPH NODE; MALE; NUCLEOTIDE SEQUENCE; PHARYNX CANCER; PRIORITY JOURNAL; PROCESS DESIGN; PROCESS DEVELOPMENT; QUANTITATIVE ASSAY; RELIABILITY; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; TUMOR VOLUME;

BASE SEQUENCE; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DNA TOPOISOMERASES, TYPE I; DNA, COMPLEMENTARY; GLUCOSEPHOSPHATE DEHYDROGENASE; HUMANS; HYDROXYMETHYLBILANE SYNTHASE; LARYNGEAL NEOPLASMS; PHARYNGEAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 26844575453     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2005.120     Document Type: Article

References (24)

1. Champoux JJ, Dulbecco R. An activity from mammalian cells that untwists superhelical DNA - a possible swivel for DNA replication (polyoma-ethidium bromide-mouse-embryo cells-dye binding assay). Proc Natl Acad Sci USA 1972;69:143-6.
2. Gupta M, Fujimori A, Pommier Y. Eukaryotic DNA topoisomerases I. Biochim Biophys Acta 1995;1262:1-14.
3. Chen BM, Chen JY, Kao M, Lin JB, Yu MH, Roffler SR. Elevated topoisomerase I activity in cervical cancer as a target for chemoradiation therapy. Gynecol Oncol 2000;79:272-80.
4. Boonsong A, Curran S, McKay JA, Cassidy J, Murray GI, McLeod HL. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases. Hum Pathol 2002;33:1114-9.
5. Kim R, Ohi Y, Inoue H, Toge T. Expression and relationship between topoisomerase I and II alpha genes in tumor and normal tissues in oesophageal, gastric and colon cancers. Anticancer Res 1999;19:5393-8.
6. Giovanella BC, Stehlin JS, Wall ME, Wani MC, Nicholas AW, Liu LF, et al. DNA topoisomerase I-targeted chemotherapy of human colon cancer in xenografts. Science 1989;246:1046-8.
7. Guichard S, Terret C, Hennebelle I, Lochon I, Chevreau P, Fretigny E, et al. CPT-11 converting carboxylesterase and topoisomerase activities in tumor and normal colon and liver tissues. Br J Cancer 1999; 80:364-70.
8. Husain I, Mohler JL, Seigler HF, Besterman JM. Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res 1994;54:539-46.
9. Staker BL, Hjerrild K, Feese MD, Behnke CA, Burgin AB Jr, Stewart L. The mechanism of topoisomerase I poisoning by a camptothecin analog. Proc Natl Acad Sci USA 2002;99:15387-92.
10. Pommier Y, Pourquier P, Fan Y, Strumberg D. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim Biophys Acta 1998;1400:83-105.
11. Garcia-Carbonero R, Supko JG. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins. Clin Cancer Res 2002;8:641-61.
12. McLeod HL, Keith WN. Variation in topoisomerase I gene copy number as a mechanism for intrinsic drug sensitivity. Br J Cancer 1996;74:508-12.
13. Jansen WJ, Zwart B, Hulscher ST, Giaccone G, Pinedo HM, Boven E. CPT-11 in human colon-cancer cell lines and xenografts: characterization of cellular sensitivity determinants. Int J Cancer 1997;70:335-40.
14. Perego P, Capranico G, Supino R, Zunino F. Topoisomerase I gene expression and cell sensitivity to camptothecin in human cell lines of different tumor types. Anticancer Drugs 1994;5:645-9.
15. Guichard S, Hennebelle I, Bugat R, Canal P. Cellular interactions of 5-fluorouracil and the camptothecin analogue CPT-11 (irinotecan) in a human colorectal carcinoma cell line. Biochem Pharmacol 1998;55:667-76.
16. Ohtsu A, Boku N, Yoshioka T, Hyodo I, Shirao K, Shimada Y, et al. A phase II study of irinotecan in combination with 120-h infusion of 5-fluorouracil in patients with metastatic colorectal carcinoma: Japan Clinical Oncology Group Study (JCOG9703). Jpn J Clin Oncol 2003;33:28-32.
17. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription-polymerase chain reaction assays. J Mol Endocrinol 2000;25:169-93.
18. Bustin SA, Nolan T. Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction 2004; 15:155-66.
19. Schmittgen TD, Zakrajsek BA. Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR 2000;46:69-81.
20. Tsuji N, Kamagata C, Furuya M, Kobayashi D, Yagihashi A, Morita T, et al. Selection of an internal control gene for quantitation of mRNA in colonic tissues. Anticancer Res 2002;22:4173-8.
21. Blanquicett C, Johnson MR, Heslin M, Diasio RB. House-keeping gene variability in normal and carcinomatous colorectal and liver tissues: applications in pharmacogenomic gene expression studies. Anal Biochem 2002;303:209-14.
22. Liu JY, Zhou W, Sferruzza AD, Bender RA. Quantitation of dihydropyrimidine dehydrogenase (DPD) mRNA expression levels in normal colon and colorectal cancer tumor paraffin-embedded tissue specimens. Anticancer Drugs 2003;14:563-7.
23. Dheda K, Huggett JF, Bustin SA, Johnson MA, Rook G, Zumla A. Validation of housekeeping genes for normalizing RNA expression in real-time PCR. Biotechniques 2004;37:112-9.
24. de Kok JB, Roelofs RW, Giesendorf BA, Pennings JL, Waas ET, Feuth T, et al. Normalization of gene expression measurements in tumor tissues. Lab Invest 2005; 85:154-9.